The data demonstrated that expression of TIGIT on CD4+ T cells is highly correlated with the SLE disease activity index (SLEDAI) suggesting TIGIT as a potential biomarker in monitoring disease activity in patients with SLE. Here, TIGIT is linked to systemic lupus erythematosus.